Literature DB >> 16557043

Cancer stem cells and differentiation therapy.

Stewart Sell1.   

Abstract

Cancers arise from stem cells in adult tissues and the cells that make up a cancer reflect the same stem cell --> progeny --> differentiation progression observed in normal tissues. All adult tissues are made up of lineages of cells consisting of tissue stem cells and their progeny (transit-amplifying cells and terminally differentiated cells); the number of new cells produced in normal tissue lineages roughly equals the number of old cells that die. Cancers result from maturation arrest of this process, resulting in continued proliferation of cells and a failure to differentiate and die. The biological behavior, morphological appearance, and clinical course of a cancer depend on the stage of maturation at which the genetic lesion is activated. This review makes a comparison of cancer cells to embryonic stem cells and to adult tis sue stem cells while addressing two basic questions: (1) Where do cancers come from?, and (2) How do cancers grow? The answers to these questions are critical to the development of approaches to the detection, prevention, and treatment of cancer.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16557043     DOI: 10.1159/000092323

Source DB:  PubMed          Journal:  Tumour Biol        ISSN: 1010-4283


  29 in total

1.  Arsenic, stem cells, and the developmental basis of adult cancer.

Authors:  Erik J Tokar; Wei Qu; Michael P Waalkes
Journal:  Toxicol Sci       Date:  2010-11-11       Impact factor: 4.849

2.  Amplification and invasiveness of epithelial progenitors during gastric carcinogenesis in trefoil factor 1 knockout mice.

Authors:  S M Karam; C Tomasetto; M-C Rio
Journal:  Cell Prolif       Date:  2008-12       Impact factor: 6.831

3.  Osteosarcoma cells differentiate into phenotypes from all three dermal layers.

Authors:  Scott Russinoff; Sara Miran; Ashok L Gowda; Paul A Lucas
Journal:  Clin Orthop Relat Res       Date:  2011-06-16       Impact factor: 4.176

4.  Regulation of glioblastoma multiforme stem-like cells by inhibitor of DNA binding proteins and oligodendroglial lineage-associated transcription factors.

Authors:  Yanjue Wu; Jean-Philippe Richard; Shervin D Wang; Prakash Rath; John Laterra; Shuli Xia
Journal:  Cancer Sci       Date:  2012-04-04       Impact factor: 6.716

5.  A novel orthotopic murine model provides insights into cellular and molecular characteristics contributing to human osteosarcoma.

Authors:  Crispin R Dass; Eugene T Ek; Karla G Contreras; Peter F Choong
Journal:  Clin Exp Metastasis       Date:  2006-12-23       Impact factor: 5.150

Review 6.  Glioma stem cell research for the development of immunotherapy.

Authors:  Jianfei Ji; Keith L Black; John S Yu
Journal:  Neurosurg Clin N Am       Date:  2010-01       Impact factor: 2.509

Review 7.  Liver cancer stem cells.

Authors:  Stewart Sell; Hyam L Leffert
Journal:  J Clin Oncol       Date:  2008-06-10       Impact factor: 44.544

Review 8.  Alpha-fetoprotein, stem cells and cancer: how study of the production of alpha-fetoprotein during chemical hepatocarcinogenesis led to reaffirmation of the stem cell theory of cancer.

Authors:  Stewart Sell
Journal:  Tumour Biol       Date:  2008-07-09

Review 9.  Epithelial stem cells and malignancy.

Authors:  Daniela E Costea; Luke Gammon; Kayoko Kitajima; Lisa Harper; Ian C Mackenzie
Journal:  J Anat       Date:  2008-07       Impact factor: 2.610

10.  Olig2-induced neural stem cell differentiation involves downregulation of Wnt signaling and induction of Dickkopf-1 expression.

Authors:  Sung-Min Ahn; Kyunghee Byun; Deokhoon Kim; Kiyoung Lee; Jong Shin Yoo; Seung U Kim; Eek-Hoon Jho; Richard J Simpson; Bonghee Lee
Journal:  PLoS One       Date:  2008-12-18       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.